SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Collagen Corp.
CGEN 1.750-1.1%Nov 3 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Luke who wrote (16)3/29/1997 6:45:00 PM
From: Rocketman   of 72
 
The Zacks EPS Forecast Revision Model sounds like a computer program to crunch numbers. I'm suspect of such systems in the biomed industry. Too much variablity and swings due to new products, etc... This isn't like analyzing some commodities business and a lot of speculation and reality checking is needed. If CGEN unloads there TGET shares, EPS would skyrocket, regardless of Zacks Indicator Ranking. This means that EPS can be totally manipulated by the CGEN management, they could do what ever they want in that regard. For a long time CGEN was buying back their own shares, with this much TGET stock, they could liquidate it and buy back half the outstanding CGEN shares at the current prices. Not what I would expect them to do, but it indicates where much of the value of the company lies.

If you're a fan of breast implants, make sure you read Posts # 6,8,10 and 13.

Dave
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext